Princeton develops bionic ear; Israel developing as med tech hotbed;

 @FierceMedDev: Boston Scientific's Watchman AF device generates more stunning data. Story | Follow @FierceMedDev

 @MarkHFierce: Swiss stent maker Bioensors Int'l will pay $51M for a U.S. imaging company - diversification program now under way. More | Follow @MarkHFierce

 @DamianFierce: Glaxo is reaching into Hong Kong with a new DKSH partnership, targeting antibiotics. Article | Follow @DamianFierce

> Princeton University researchers have come up with a bionic ear, made from a 3-D printer, with a radio antenna woven into the cartilage. Story

> Austria's MED-EL Medical Electronics says a Toronto patient can now hear music and voices thanks to the successful implantation of its Bonebridge bone conduction hearing implant. Release

> Tyrx, a 2012 Fierce 15 winner, is celebrating new study results showing its AigisRx antibacterial envelope slashed major infection rates by more than 90% in patients undergoing cardiovascular device (pacemaker or ICD) implant replacement procedures. Release

> Welch Allyn has launched its next-generation Connex vital signs monitor in Canada, touting the device as providing more accurate diagnoses than competing products. More

> Self-expanding stents can greatly improve outcomes for patients with heart disease, The Times of India reports. Story

> Israel's medical device industry is still relatively new, but its potential is beginning to mushroom. Item

Biotech News

 @FierceBiotech:  FDA accepts $BIIB's BLA for 1st long-lasting factor VIII therapy for hemophilia A. Release | Follow @FierceBiotech

 @JohnCFierce: J&J gets a priority review for hep C drug simeprevir (with Medivir). More | Follow @JohnCFierce

 @RyanMFierce:  Mobile service PharmaSecure finds demand in losing fight against fake drugs. Story | Follow @RyanMFierce

> Vectura joins forces with a new JV biotech in China for respiratory therapies. News

> Class action suits pile up at Aveo's doorstep in wake of FDA debacle. More

> Elan pays $1B for a slice of Theravance's COPD franchise royalty stream. News

Pharma News

 @FiercePharma: FDA nixes Endo petition to protect Opana ER from generics. Article | Follow @FiercePharma

> AbbVie research chief heads for the exits, amid rash of top R&D departures. Story

> Actavis, Warner Chilcott in buyout talks worth $5B-plus. Article

> GlaxoSmithKline's Breo nod augurs new respiratory franchise, analysts say. More

CRO News

> Argentine CRO Stat Research taps Datatrak. News

> Harlan Labs doubles in specialty research with U.S. expansion. Story

> PRA boosts informatics with Welsh expansion. More

> Quintiles hauls in $947M IPO after upping offering. Report

> AMRI piles on profits with strong Q2. Article

Biotech IT News

> Pfizer tests online Viagra sales to beat the cheats. News

> IT outfit Instem acquires Logos to penetrate early clinical trials market. More

> GlaxoSmithKline exec details expectations for online clinical trial research. Article

> Hong Kong billionaire backs Big Data effort in biomedicine at Oxford University. Story

> Pfizer opts to keep running Accelrys software in its labs. Article

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,